Uterine disorders and iron deficiency anemia

review OA: green public-domain-us
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This review discusses the mechanisms linking uterine disorders like leiomyomas, adenomyosis, polyps, and cesarean scar defects to abnormal uterine bleeding and subsequent iron deficiency anemia.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text ⓘ

This 2022 review discusses abnormal uterine bleeding (AUB) as a cause of iron deficiency anemia and outlines mechanisms linking uterine disorders to AUB using the PALM-COEIN classification, spanning structural and non-structural etiologies. It highlights that heavy menstrual bleeding is more closely related to uterine fibroids, while noting that the connection remains poorly characterized—especially regarding endometrial function in women with structural myometrial features. For uterine adenomyosis, it summarizes evidence that its pathogenesis is multifactorial, with theories including direct invasion of the myometrium by endometrial cells versus de novo development, and it emphasizes a tissue injury-and-repair model for lesion development; the review also covers other AUB causes such as endometrial polyps and cesarean scar defects. Relevance to endometriosis: the paper does not explicitly discuss endometriosis, but it centers on adenomyosis as a key uterine disorder in AUB-related iron deficiency anemia. This paper is centrally about adenomyosis — it reviews mechanisms by which adenomyosis causes abnormal uterine bleeding leading to iron deficiency anemia.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abnormal uterine bleeding (AUB) is a clinical entity which can lead to iron deficiency anemia. Classification according to the acronym PALM-COEIN (polyp, adenomyosis, leiomyoma, malignancy, and hyperplasia; coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, and not otherwise classified) provides a structured approach to establish the cause of AUB. The goal of this review is to discuss the different mechanisms and the relationship between uterine disorders and AUB. Heavy menstrual bleeding, a subgroup of AUB, is more closely related to the presence of uterine fibroids. The relationship between heavy menstrual bleeding and uterine fibroids remains poorly characterized, particularly the understanding of endometrial function in women with structural myometrial features such as leiomyomas. A number of theories have been proposed in the literature and are discussed in this review. Uterine adenomyosis is also a frequent cause of AUB, and its pathogenesis is still far from being fully elucidated. The mechanisms contributing to its development are multifactorial. Many theories lean toward invasion of the myometrium by endometrial cells. Both clinical and basic studies favor the theory of direct invasion, although de novo development of adenomyosis from Müllerian rests or stem cells has not been ruled out. Development of adenomyotic lesions involves repeated tissue injury and repair. In addition, this review describes the other causes of AUB such as endometrial polyps, cesarean scar defects, and uterine vascular abnormalities. Endometrial polyps are often asymptomatic, but approximately 68% of women have concomitant AUB. Histologic alterations in the lower uterine segment in patients who had undergone cesarean sections were identified and may explain the cause of AUB.
Full text 2,452 characters · extracted from oa-html · click to expand
Uterine disorders and iron deficiency anemia. (2022) Fertility and sterility — Vol. 118, n° 4, p. 615-624 (2022) (2022) Fertility and sterility — Vol. 118, n° 4, p. 615-624 (2022) Open Access - Adobe PDF - 754.14 KB - Authors - Author Donnez, Jacques - Author Carmona, Francisco - Author Maitrot-Mantelet, Lorraine - Author - Author Chapron, Charles - Abstract - Abnormal uterine bleeding (AUB) is a clinical entity which can lead to iron deficiency anemia. Classification according to the acronym PALM-COEIN (polyp, adenomyosis, leiomyoma, malignancy, and hyperplasia; coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, and not otherwise classified) provides a structured approach to establish the cause of AUB. The goal of this review is to discuss the different mechanisms and the relationship between uterine disorders and AUB. Heavy menstrual bleeding, a subgroup of AUB, is more closely related to the presence of uterine fibroids. The relationship between heavy menstrual bleeding and uterine fibroids remains poorly characterized, particularly the understanding of endometrial function in women with structural myometrial features such as leiomyomas. A number of theories have been proposed in the literature and are discussed in this review. Uterine adenomyosis is also a frequent cause of AUB, and its pathogenesis is still far from being fully elucidated. The mechanisms contributing to its development are multifactorial. Many theories lean toward invasion of the myometrium by endometrial cells. Both clinical and basic studies favor the theory of direct invasion, although de novo development of adenomyosis from Müllerian rests or stem cells has not been ruled out. Development of adenomyotic lesions involves repeated tissue injury and repair. In addition, this review describes the other causes of AUB such as endometrial polyps, cesarean scar defects, and uterine vascular abnormalities. Endometrial polyps are often asymptomatic, but approximately 68% of women have concomitant AUB. Histologic alterations in the lower uterine segment in patients who had undergone cesarean sections were identified and may explain the cause of AUB. - Affiliations - APA - Chicago - FWB Donnez, J., Carmona, F., Maitrot-Mantelet, L., Dolmans, M.-M., & Chapron, C. (2022). Uterine disorders and iron deficiency anemia. Fertility and sterility, 118(4), 615-624. https://doi.org/10.1016/j.fertnstert.2022.08.011 (Original work published 2022)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-25T06:10:54.854274+00:00
pubmed
last seen: 2026-09-10T06:15:39.278259+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine